» Articles » PMID: 30835243

Diagnostic Performance of a Smart Device With Photoplethysmography Technology for Atrial Fibrillation Detection: Pilot Study (Pre-mAFA II Registry)

Overview
Date 2019 Mar 6
PMID 30835243
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. The asymptomatic nature and paroxysmal frequency of AF lead to suboptimal early detection. A novel technology, photoplethysmography (PPG), has been developed for AF screening. However, there has been limited validation of mobile phone and smart band apps with PPG compared to 12-lead electrocardiograms (ECG).

Objective: We investigated the feasibility and accuracy of a mobile phone and smart band for AF detection using pulse data measured by PPG.

Methods: A total of 112 consecutive inpatients were recruited from the Chinese PLA General Hospital from March 15 to April 1, 2018. Participants were simultaneously tested with mobile phones (HUAWEI Mate 9, HUAWEI Honor 7X), smart bands (HUAWEI Band 2), and 12-lead ECG for 3 minutes.

Results: In all, 108 patients (56 with normal sinus rhythm, 52 with persistent AF) were enrolled in the final analysis after excluding four patients with unclear cardiac rhythms. The corresponding sensitivity and specificity of the smart band PPG were 95.36% (95% CI 92.00%-97.40%) and 99.70% (95% CI 98.08%-99.98%), respectively. The positive predictive value of the smart band PPG was 99.63% (95% CI 97.61%-99.98%), the negative predictive value was 96.24% (95% CI 93.50%-97.90%), and the accuracy was 97.72% (95% CI 96.11%-98.70%). Moreover, the diagnostic sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of mobile phones with PPG for AF detection were over 94%. There was no significant difference after further statistical analysis of the results from the different smart devices compared with the gold-standard ECG (P>.99).

Conclusions: The algorithm based on mobile phones and smart bands with PPG demonstrated good performance in detecting AF and may represent a convenient tool for AF detection in at-risk individuals, allowing widespread screening of AF in the population.

Trial Registration: Chinese Clinical Trial Registry ChiCTR-OOC-17014138; http://www.chictr.org.cn/showproj.aspx?proj=24191 (Archived by WebCite at http://www.webcitation/76WXknvE6).

Citing Articles

Recent advances in the tools and techniques for AI-aided diagnosis of atrial fibrillation.

Islam S, Islam M, Sanjid-E-Elahi , Abedin M, Dokeroglu T, Rahman M Biophys Rev (Melville). 2025; 6(1):011301.

PMID: 39831069 PMC: 11737893. DOI: 10.1063/5.0217416.


Smartwatch-based algorithm for early detection of pulmonary infection: Validation and performance evaluation.

Chen Y, She D, Guo Y, Chen W, Li J, Li D Digit Health. 2024; 10:20552076241290684.

PMID: 39465220 PMC: 11512465. DOI: 10.1177/20552076241290684.


Improving the management of patients with chronic cardiac and respiratory diseases by extending pulse-oximeter uses: the dynamic pulse-oximetry.

Nardini S, Corbanese U, Visconti A, Mule J, Sanguinetti C, De Benedetto F Multidiscip Respir Med. 2024; 18(1):922.

PMID: 38322131 PMC: 10772858. DOI: 10.4081/mrm.2023.922.


Detection and Diagnostic Accuracy of Cardiac Arrhythmias Using Wearable Health Devices: A Systematic Review.

Tran H, Urgessa N, Geethakumari P, Kampa P, Parchuri R, Bhandari R Cureus. 2024; 15(12):e50952.

PMID: 38249280 PMC: 10800119. DOI: 10.7759/cureus.50952.


[Application of photoplethysmography for atrial fibrillation in early warning, diagnosis and integrated management].

Tai M, Jin Z, Wang H, Guo Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023; 40(6):1102-1107.

PMID: 38151932 PMC: 10753309. DOI: 10.7507/1001-5515.202206005.


References
1.
Islam M, Ammour N, Alajlan N, Aboalsamh H . Rhythm-based heartbeat duration normalization for atrial fibrillation detection. Comput Biol Med. 2016; 72:160-9. DOI: 10.1016/j.compbiomed.2016.03.015. View

2.
Guo Y, Tian Y, Wang H, Si Q, Wang Y, Lip G . Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest. 2014; 147(1):109-119. DOI: 10.1378/chest.14-0321. View

3.
Kotecha D, Breithardt G, Camm A, Lip G, Schotten U, Ahlsson A . Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. Europace. 2018; 20(3):395-407. DOI: 10.1093/europace/eux318. View

4.
Tison G, Sanchez J, Ballinger B, Singh A, Olgin J, Pletcher M . Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch. JAMA Cardiol. 2018; 3(5):409-416. PMC: 5875390. DOI: 10.1001/jamacardio.2018.0136. View

5.
Potpara T, Lip G . Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk. Prog Cardiovasc Dis. 2015; 58(2):177-94. DOI: 10.1016/j.pcad.2015.07.003. View